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Steroid-resistantnephroticsyndrome(SRNS)isacommonprobleminpediatricnephrologypractice.Thereiscurrentlylittleinfor-
mation in the literature on the spectrum of histopathologic lesions in children presenting with SRNS in Pakistan. This study was
designed to determine the histopathologic lesions in children presenting with SRNS at our center. The study was conducted at the
Histopathology Department, Sindh Institute of Urology and Transplantation (SIUT) from January 2009 to August 2011. All chil-
dren (≤16 years) presenting with SRNS, in whom renal biopsies were performed, were included. Their demographic, clinical,
laboratory, and histopathological data were retrieved from ﬁles and original renal biopsy forms. The results were analyzed by SPSS
version 10.0. A total of 147 children were included. Of these, 91 (61.9%) were males and 56 (38.1%) females, with male-to-female
ratio of 1.6:1. The mean age was 7.03 ± 4.0 years (range: 6 months–16 years). The histopathological lesions seen on renal biopsies
comprisedoffocalsegmentalglomerulosclerosis(FSGS)(38.5%),followedbyminimalchangedisease(MCD)(23.2%),IgMneph-
ropathy (IgMN) (13.6%), idiopathic mesangial proliferative GN (10.2%), membranous GN (8.2%), and mesangiocapillary GN
(4.8%). Our results indicate that FSGS is the predominant lesion in children with SRNS, followed by MCD and IgMN.
1.Introduction
Steroid-resistant nephrotic syndrome (SRNS) is a common
problem in pediatric nephrology practice and one that poses
signiﬁcant therapeutic challenge for pediatric nephrologists
[1–4]. The children with SRNS tend to progress to end-stage
renal disease (ESRD) due to the progressive damage of the
glomerular ﬁltration barrier (GFB) [5–8]. The frequency of
SRNS among all cases of idiopathic nephrotic syndrome
(INS) varies throughout the world [9–13]. Reported rates of
steroid resistance among the biopsy series vary from 10 to
20% in diﬀerent studies. We have found earlier a steroid-
resistant pattern of INS in 30% of our children who under-
went renal biopsy [14] .T h e r ea r ev e r yf e ws t u d i e si nt h e
literature on the histopathological spectrum of glomeru-
lopathies underlying SRNS in children [9–12]. Some authors
have suggested that the underlying histopathology aﬀects
the course of SRNS and its response to treatment. There is
currently little information about the histopathologic spec-
trum of lesions in children presenting with SRNS in Pakistan
[15, 16]. There are also data in the literature that suggest that
thepatternofhistopathologyunderlyingINSischangingnot
only in adults but also in children [17–20]. It then became
imperative to determine the true pattern of the prevailing
glomerulopathies underlying SRNS in a large cohort of chil-
dren who presented to our center.
This study was thus designed to determine the spectrum
ofhistopathologicallesionsinchildrenpresentingwithSRNS
at our center.
2.MaterialandMethods
This descriptive, observational study was conducted from
January 2009 till August 2011 at the Department of Histo-
pathology, Sindh Institute of Urology and Transplantation
(SIUT). All children presenting with SRNS at the Pediatric2 The Scientiﬁc World Journal
Nephrology Outpatient Department of SIUT and in whom
renal biopsies were performed during the above-mentioned
period were included. Their demographic, clinical, and lab-
oratory data at the time of presentation and on last followup
were retrieved from case ﬁles. The histopathological ﬁndings
including light microscopy (LM) and immunoﬂourescence
(IF)ﬁndingswererecordedfromoriginalrenalbiopsyforms.
Standard deﬁnitions of the disease and treatment responses
were used as in our previous study [14]. Informed consent
was obtained from the children or their parents before ob-
taining real-time ultrasound-guided percutaneous renal bio-
psies by automated biopsy gun.
2.1. Pathologic Study. At our center, two cores of native renal
biopsy are routinely obtained for full pathologic evaluation
as described in detail in our previous paper [14]. One core
i sp r o c e s s e df o rL Ma n dﬁ x e di n1 0 %b u ﬀered formalin.
The other core is divided into two pieces under dissection
microscope for electron microscopic (EM) and IF study. All
biopsies were examined by the same two experienced renal
pathologists (J. I. Kazi and M. Mubarak) jointly in close
liaison with nephrologists to arrive at the best possible
correlative diagnosis. This ensured consistency and unifor-
mity of diagnostic categories and the pathological diagnoses
throughout the study period.
2.2. LM. For LM, routinely 10 serial sections are cut and
stained by hematoxylin and eosin (H and E), Masson’s
trichrome, periodic acid-Schiﬀ (PAS), and silver stains
(Gomori’s methenamine silver, GMS). In our laboratory,
renal tissue sections are cut at a thickness of 2um for optimal
evaluation of the morphologic details as reported previously
[14].
2.3.IF. Tissue specimens forIF are snap-frozenin liquid nit-
rogenandcutoncryotome.Thetissueisstainedbythedirect
method using ﬂuorescein isothiocyanate- (FITC-) conju-
g a t e da n t i s e r am o n o s p e c i ﬁ cf o rI g G ,I g A ,I g M ,C 3 ,a n dC 1 q
(Dako, Glostrup, Denmark). The slides are visualized under
the epiﬂuorescense microscope and graded semiquantita-
tively as 0 to 3+ (on a scale of 0 to 3+, where 0 = absent and
3+ = brightest) and distribution described as membranous
or mesangial in a granular or liner pattern as described pre-
viously [14]. IF ﬁndings on the biopsy specimens were ob-
tained from the original renal biopsy reports.
2.4. EM. Tissue samples for EM were processed as described
in our previous report [14]. Brieﬂy, EM tissue was ﬁxed in
4% glutaraldehyde, postﬁxed in 1% osmium tetroxide at
0.02M Sorenson Phosphate buﬀer at pH 7.4, processed for
EM, and embedded in Eponate resin. Ultra-thin sections
(100nm) were cut on Leica ultramicrotome. Sections were
stained on copper 300-mesh girds with Uranyl acetate and
Lead citrate and examined with a JEM 1200 EX II electron
microscope.
2.5. Final Diagnosis. This was made by correlating the
entire clinical, laboratory, and the pathological ﬁndings. The
ﬁnal diagnosis was retrieved from the original renal biopsy
reports. Standard deﬁnitions of the diseases were utilized for
Figure 1:Medium-powerviewshowingaglomeruluswithsegmen-
tal scarring associated with intracapillary foam cells and adhesion
formation with Bowman’s capsule, in a case of classic focal segmen-
tal glomerulosclerosis. (Silver stain, ×200).
Figure 2:Low-power view ofarepresentative sectionofarenalbio-
psy showing ﬁve glomeruli with minor changes. There is no seg-
mental scarring or signiﬁcant mesangial proliferation. One small
artery included as well as the surrounding tubulointerstitial com-
partment show no signiﬁcant pathology. This case was diagnosed as
minimal change disease after IF study showed negative results and
EM showed diﬀuse eﬀacement of foot processes. (Silver stain,
×100).
the pathological categorization of the glomerular lesions as
in our previous study, and shown in Figures 1–4 [14].
2.6. Statistical Methods. Statistical analysis was carried out
using IBM compatible SPSS for windows version 10.0 (SPSS,
Chicago, IL, USA). Simple descriptive statistics such as
mean ± SD were used for variables such as age and clinical
andlaboratoryfeatures.Percentageswereusedforcategorical
data.
3. Results
Atotalof147pediatricpatientswithSRNSandinwhomper-
cutaneous renal biopsies were performed were included. Of
these, 91 (61.9%) were males and 56 (38.1%) females with
the male-to-female ratio of 1.6:1. The mean age at presenta-
tionwas7.03±4.0 yearswitharangeof6monthsto16years.
Majority of children were young, with only 21% belonging
to the adolescent age group (12–16 years). The demographic
characteristics of all children with SRNS are given in Table 1.The Scientiﬁc World Journal 3
Figure 3: Medium-power view showing a glomerulus with mild
mesangial prominence, but no signiﬁcant increase in mesangial
hypercellularity. This case latter turned out to be IgM nephropathy
after IF showed diﬀuse granular mesangial positivity of IgM, as
shown in Figure 4. (PAS stain, ×200).
Figure 4: Medium-power view showing a glomerulus with diﬀuse
granular mesangial positivity of IgM on IF study. (IgM, ×200).
The spectrum of histopathological lesions seen on renal
biopsies was wide and comprised of focal segmental glome-
rulosclerosis (FSGS) (38.7%), followed by minimal change
disease (MCD) (23.1%), IgM nephropathy (13.6%), idiopa-
thic mesangial proliferative GN (MesPGN) (10.2%), mem-
branous GN (MN) (8.2%), mesangiocapillary or membra-
noproliferative GN (MPGN) (4.8%), and a number of rare
lesions (Table 2). These results demonstrate the predomi-
nance of FSGS in children with SRNS. MCD was second in
frequency, followed by IgMN. The later disease is a relatively
recently described and still largely controversial entity, which
is again at the forefront of nephropathology literature. A
comparison of the common histopathological lesions in our
study with local and international studies is given in Table 3.
4. Discussion
This is one of the largest studies on the spectrum of histo-
pathologicallesionsunderlyingSRNSinchildrenandadoles-
cents from a single center located in the southern metropoli-
tan city of Karachi in Pakistan. We believe that the results
of this study represent the true pattern of glomerulopathies
in children presenting with SRNS from this part of the
world. This is because our renal pathology laboratory is the
only laboratory in the country that is equipped with all the
Table 1: Patient characteristics.
Total number of patients 147
Males 91 (61.9%)
Females 56 (38.1%)
Male-to-female ratio 1.6:1
Mean age (in years) 7.03 ±4.0
Age range (6 months–16 years)
Table 2: The frequency distribution of diﬀerent histopathological
lesions in 147 pediatric patients with steroid-resistant nephrotic
syndrome.
Pathological lesions Frequency Percentage
Focal segmental glomerulosclerosis 57 38.7
Minimal change disease 34 23.1
IgM nephropathy 20 13.6
Mesangioproliferative GN 15 10.2
Membranous GN 12 8.2
Mesangiocapillary GN 7 4.8
IgA nephropathy 1 0.6
Chronic sclerosing GN 1 0.6
Total 147 100
necessary modalities including IF and EM that are required
for the complete evaluation of renal biopsies. This may seem
a routine matter in most of the laboratories in the developed
world, but the situation in developing countries is just the
opposite. Moreover, although our center is located in the
southern part of the country and our catchment area mostly
comprises of southern provinces of Sindh and Balochistan,
but we receive patients from all over the country. This is
because SIUT oﬀers free consultation and treatment to all
patients with kidney diseases [21].
There is still controversy over the role of renal biopsy in
the management of SRNS children [12]. Earlier reports sug-
gested that the outcome of the disease can be predicted from
the clinical response to steroids, and the biopsy is unneces-
sary for a vast preponderance of children with INS [9]. More
recent evidence suggests that the histopathological spectrum
of glomerulopathies underlying INS is changing in both
adults and children [17–20]. Many authors have found a rise
in the prevalence of FSGS in children during the recent past,
and since this lesion is associated with a signiﬁcantly lower
response to steroids than MCD, it is recommended to detect
its presence on renal biopsy in order to better inform the
patients about the long-term prognosis. These authors also
recommend a renal biopsy before potentially nephrotoxic
drugs, such as Cyclosporine are started [7, 12, 14, 16].
Theresultsofourstudyaregenerallysimilartothosepre-
viously reported in the literature. All the previously reported
studies have observed a higher prevalence of FSGS in this
form of INS [10–13]. The incidence of this lesion is increas-
ing throughout the world not only in adults but also the chil-
dren [7]. The rates of FSGS diagnosis are not uniform across
the world, however. A study from India found FSGS in4 The Scientiﬁc World Journal
Table 3: Comparison of histopathological lesions of our study with local and international studies (all ﬁgures are in percentages).
Histopathological lesions Our study Olowu et al. [10]K a r i e t a l . [ 11] Gulati et al. [12] Azhar et al. [16]
FSGS 38.7 39.1% 39 58.8 28.8
MCD 23.1 4.3 8 17.6 13.3
IgMN 13.6 — 28 — 17.6
MesPGN 10.2 8.7 17 17.6 8.8
MN 8.2 4.3 — 1.4 13.3
MPGN 4.8 43.5 — 1.6 11.5
IgAN 0.6 — 3 — 6.6
FSGS:focalsegmentalglomerulosclerosis;IgANL:IgAnephropathy;IgMN:IgMnephropathy;MCD:minimalchangedisease;MesPGN:mesangioproliferative
GN; MN: membranous GN; MPGN: mesangiocapillary or membranoproliferative GN.
50% of cases of SRNS children [12]. A similar rate was
also reported in the studies from Saudi Arabia and Tunisia
[13, 22]. In contrast, FSGS was less common in studies from
Japan, France, and Kuwait [3, 6, 8]. The reasons for the dis-
crepancies in the results are not exactly known, but may be
relatedtoracial,genetic,orenvironmentalfactors.Moreover,
slight diﬀerences in disease deﬁnitions and inclusion criteria
may be partly responsible. One important factor, which
should also be considered, is that of observer variation in
the reporting of renal lesions, especially of MCD, mesangial
proliferative GN, and early FSGS [14, 22]. The lesions of
early FSGS may be missed easily if not sought carefully by
examiningmultiplesectionsoftherenalbiopsy.Allourbiop-
sies were examined by trained renal pathologists with vast
work and research experience, and it is extremely unlikely
that we missed the diagnosis of this lesion. The frequency of
FSGS was slightly less than that observed in the subgroup of
I N Sw i t hS R N Si no u re a r l i e rr e p o r t[ 14]. The exact reason
for this change is not known but may be partly due to the
lower threshold of upper age limit of children included in
the present study. It is worthy to mention here that the ado-
lescents constituted only 21% of all children with SRNS in
the present study.
Overall, MCD is the most common cause of INS in chil-
dren, especially under six years of age. However, its incidence
in SRNS is lower than that of FSGS in most of the reported
studies [10–13]. Our ﬁndings also concur with these studies.
Only a few studies found MCD as more common than
FSGS in children with SRNS [3, 6, 8]. The reasons for this
paradoxical ﬁnding are not known but may be related to
environmental, genetic, or racial factors [22].
IgMN is a relatively new entrant to the list of glomeru-
lopathies underlying INS both in children and adults. How-
ever,itsstatusasadistinctentityorevenitsexistenceisunder
debate till date. The disease was ﬁrst described in 1978 by
two independent groups of investigators [23, 24]. A ﬂurry of
publications soon followed from diﬀerent parts of the world,
but the interest in the disease soon faded in the western
world [25]. More recently, a number of reports have emerged
mostly from tropical countries [26, 27]. We have also pub-
lishedourexperienceofthediseaseinoneofthelargeststud-
ies of IgMN in children presenting with INS at our center
[21]. In the current study, IgMN was found in 13.6% of chil-
dren with SRNS. There is a need of collaboration between
the nephrology centers in the developed and the developing
countries for undertaking basic research to explore the etiol-
ogy and the pathogenesis of the condition.
MN was less common in our children with SRNS as in
almostallpreviouslypublishedseriesonthissubject[10–16].
In conclusion, our results indicate that FSGS is the pre-
dominant lesion in children with SRNS, followed by MCD
and IgMN. The study deﬁnes the true spectrum of histo-
pathologicallesionsunderlyingSRNSinchildreninPakistan.
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